Lexicon Pharmaceuticals
LXRX
#6305
Rank
ยฃ0.77 B
Marketcap
ยฃ1.74
Share price
-0.21%
Change (1 day)
122.94%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -ยฃ19.45 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ69.64 Million. In 2025 the company made an earning of -ยฃ37.35 Million, an increase over its 2024 earnings that were of -ยฃ0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ19.45 Million-47.92%
2025 -ยฃ37.35 Million-74.88%
2024 -ยฃ0.15 Billion13.15%
2023 -ยฃ0.14 Billion73.74%
2022 -ยฃ75.63 Million16.16%
2021 -ยฃ65.1 Million49.82%
2020 -ยฃ43.46 Million-147.19%
2019 ยฃ92.07 M-203.42%
2018 -ยฃ89.04 Million-15.31%
2017 -ยฃ0.11 Billion0.2%
2016 -ยฃ0.11 Billion2920.7%
2015 -ยฃ3.48 Million-95.33%
2014 -ยฃ74.46 Million-3.61%
2013 -ยฃ77.25 Million-5.52%
2012 -ยฃ81.76 Million-4.17%
2011 -ยฃ85.32 Million15.5%
2010 -ยฃ73.87 Million8.36%
2009 -ยฃ68.17 Million-4.81%
2008 -ยฃ71.61 Million28.79%
2007 -ยฃ55.61 Million35.71%
2006 -ยฃ40.98 Million52.91%
2005 -ยฃ26.8 Million-23.89%
2004 -ยฃ35.21 Million-24.19%
2003 -ยฃ46.44 Million-0.48%
2002 -ยฃ46.66 Million44.12%
2001 -ยฃ32.38 Million23.01%
2000 -ยฃ26.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ5.50 B-28,547.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ0.86 B-4,546.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ3.82 B-19,865.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ0.4 Billion 1,956.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.14 B-830.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ58.89 M-404.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ17.25 Million-10.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.28 B-1,577.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ11.07 Million-42.82%๐Ÿ‡บ๐Ÿ‡ธ USA